BlackRock’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$81.4M Sell
16,153,190
-388,140
-2% -$1.96M ﹤0.01% 2157
2025
Q1
$107M Buy
16,541,330
+78,613
+0.5% +$509K ﹤0.01% 1931
2024
Q4
$121M Buy
16,462,717
+86,911
+0.5% +$638K ﹤0.01% 1949
2024
Q3
$123M Sell
16,375,806
-58,316
-0.4% -$437K ﹤0.01% 1948
2024
Q2
$146M Sell
16,434,122
-129,490
-0.8% -$1.15M ﹤0.01% 1792
2024
Q1
$168M Sell
16,563,612
-300,967
-2% -$3.05M ﹤0.01% 1748
2023
Q4
$170M Buy
16,864,579
+1,060,666
+7% +$10.7M ﹤0.01% 1730
2023
Q3
$148M Buy
15,803,913
+1,828,956
+13% +$17.1M ﹤0.01% 1731
2023
Q2
$343M Buy
13,974,957
+19,466
+0.1% +$478K 0.01% 1187
2023
Q1
$325M Sell
13,955,491
-181,137
-1% -$4.22M 0.01% 1204
2022
Q4
$358M Buy
14,136,628
+262,902
+2% +$6.65M 0.01% 1109
2022
Q3
$267M Buy
13,873,726
+1,062,036
+8% +$20.5M 0.01% 1254
2022
Q2
$326M Buy
12,811,690
+7,415,506
+137% +$189M 0.01% 1154
2022
Q1
$139M Buy
5,396,184
+88,135
+2% +$2.27M ﹤0.01% 1901
2021
Q4
$222M Buy
5,308,049
+148,420
+3% +$6.21M 0.01% 1651
2021
Q3
$225M Buy
5,159,629
+177,991
+4% +$7.75M 0.01% 1617
2021
Q2
$236M Sell
4,981,638
-303,802
-6% -$14.4M 0.01% 1634
2021
Q1
$271M Sell
5,285,440
-163,037
-3% -$8.36M 0.01% 1491
2020
Q4
$146M Buy
5,448,477
+1,374,316
+34% +$36.8M ﹤0.01% 1820
2020
Q3
$140M Buy
4,074,161
+212,472
+6% +$7.29M 0.01% 1658
2020
Q2
$158M Buy
3,861,689
+3,417,871
+770% +$140M 0.01% 1509
2020
Q1
$15.2M Buy
443,818
+166,769
+60% +$5.71M ﹤0.01% 2710
2019
Q4
$3.49M Buy
+277,049
New +$3.49M ﹤0.01% 3556